{
    "clinical_study": {
        "@rank": "40384", 
        "brief_summary": {
            "textblock": "The purpose of this study is to assess the efficacy of tryptophan vs. placebo, and voucher\n      payments vs. a control condition, in the treatment of cocaine dependence."
        }, 
        "brief_title": "Tryptophan and Behavior Therapy for Cocaine Abuse - 1", 
        "completion_date": "April 2001", 
        "condition": "Cocaine-Related Disorders", 
        "condition_browse": {
            "mesh_term": "Cocaine-Related Disorders"
        }, 
        "detailed_description": {
            "textblock": "This clinical trial uses a 2 by 2 design to compare tryptophan to placebo, and voucher\n      incentives vs. a control condition, in the outpatient treatment of cocaine dependence- using\n      a relapse prevention model of treatment intervention."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Cocaine dependent\n\n        Exclusion Criteria:\n\n          -  Physically dependent on drugs of abuse other than cocaine\n\n          -  Significant medical or psychiatric illness (besides substance abuse disorder)\n\n          -  Pregnant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": "200", 
        "firstreceived_date": "September 20, 1999", 
        "id_info": {
            "nct_id": "NCT00000324", 
            "org_study_id": "NIDA-10754-1", 
            "secondary_id": "R01-10754-1"
        }, 
        "intervention": {
            "intervention_name": "Tryptophan", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Tryptophan"
        }, 
        "lastchanged_date": "November 3, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Baltimore", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "21224"
                }, 
                "name": "Johns Hopkins University School of Medicine"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Tryptophan and Behavior Therapy for Cocaine Abuse", 
        "overall_official": {
            "affiliation": "Johns Hopkins University", 
            "last_name": "Eric C Strain, M.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 2", 
        "primary_outcome": [
            {
                "measure": "Side effects"
            }, 
            {
                "measure": "Retention"
            }, 
            {
                "measure": "Cocaine use"
            }, 
            {
                "measure": "Cocaine craving"
            }, 
            {
                "measure": "Other drug use"
            }, 
            {
                "measure": "Psychosocial functioning"
            }
        ], 
        "reference": [
            {
                "citation": "Jones H.E., Johnson, R.E., Bigelow G.E., Strain E.C. Differences at treatment entry between opioid-dependent and cocaine-dependent males and females. Addictive Disorders and Their Treatment 3:110-121, 2004."
            }, 
            {
                "PMID": "15764421", 
                "citation": "Jones HE, Johnson RE, Bigelow GE, Silverman K, Mudric T, Strain EC. Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial. Am J Addict. 2004 Oct-Dec;13(5):421-37."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00000324"
        }, 
        "source": "National Institute on Drug Abuse (NIDA)", 
        "sponsors": {
            "collaborator": {
                "agency": "Johns Hopkins University", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Institute on Drug Abuse (NIDA)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "March 1997", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Masking: Double-Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2005"
    }, 
    "geocoordinates": {
        "Johns Hopkins University School of Medicine": "39.29 -76.612"
    }
}